Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.1500
+0.0200 (15.38%)
At close: Mar 17, 2026
Vectus Biosystems Market Cap
Vectus Biosystems has a market cap or net worth of 8.02 million as of March 27, 2026. Its market cap has decreased by -57.55% in one year.
Market Cap
8.02M
Enterprise Value
8.15M
Revenue
89.96K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since February 23, 2016, Vectus Biosystems's market cap has decreased from 36.22M to 8.02M, a decrease of -77.87%. That is a compound annual growth rate of -13.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 8.02M | -16.67% |
| Dec 31, 2025 | 9.62M | 134.56% |
| Dec 23, 2024 | 4.10M | -74.31% |
| Dec 29, 2023 | 15.96M | -58.89% |
| Dec 30, 2022 | 38.83M | -15.39% |
| Dec 31, 2021 | 45.89M | 20.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Patrys | 15.53M |
| Immuron | 10.78M |
| AdAlta | 10.20M |
| Bio-Gene Technology | 9.76M |
| Tissue Repair | 9.07M |
| Chimeric Therapeutics | 8.84M |
| Invex Therapeutics | 7.52M |
| Biotron | 6.75M |